Basilea seeks approval of ceftobiprole in Europe

Basilea Pharmaceutica AG (SIX:BSLN) submitted an MAA in Europe for ceftobiprole to treat pneumonia in the hospital setting. The application was submitted under the EU's decentralized procedure. Ceftob...